Cantor Fitzgerald assumed coverage of Vertex Pharmaceuticals (VRTX) with an Overweight rating and $535 price target Stay Ahead of the Market: ...

For his part, Natan Nakel, Creative Coordinator at Control F5, spearheaded the rebranding process, creating a visual identity ...